Clinical Trial Update: A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV [Phase 1]

View source ↗

Summary

This is a Phase 1 trial update announcing completion of a Phase 1 study evaluating the MVA85A tuberculosis vaccine in healthy volunteers, including participants…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MVA85A (Modified Vaccinia Ankara expressing antigen 85A)

Snippet

Sponsor: University of Oxford | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED